Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Duloxetine Plus Alpha-Lipoic Acid in Painful Diabetic Peripheral Neuropathy
NCT07785544Not yet recruiting
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Aug 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Randomised, single-blind trial in diabetic peripheral neuropathy (DPN) comparing Duloxetine 30 mg + Alpha-Lipoic Acid 600 mg with Duloxetine 60 mg (2 arms). Primary endpoint: Change in pain intensity measured by Numerical Rating Scale at 9 weeks. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
duloxetinealpha-lipoic acid
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT07785544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07785544.